Gene therapy shows early promise for treating obesity

Mar 09, 2009

With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.

" significantly increases the risk for diabetes, cardiovascular disease, stroke and some cancers," says Dr. Matthew During, senior author and professor in Ohio State Medical Center's department of molecular virology, immunology and . "Our findings represent a promising new treatment for obesity that could ultimately provide a much safer and more effective approach than some conventional therapies."

Scientists have discovered that a particular gene, BDNF, can result in improved , reduced fat mass and weight loss when active in the hypothalamus. The findings are published online in the journal .

According to first author Lei Cao, assistant professor in the department of molecular virology, immunology and medical genetics, the study involved injecting the BDNF gene in normal mice, diabetic mice and mice fed with a high fat diet, to determine how the gene transfer would affect their weight. "The gene was active in the overweight mice, but as they lost weight the was essentially 'dialed down,' using a novel approach, thus stopping the weight from continuing to decrease and allowing a stable target weight to be reached," she says.

During indicated that with the initial results showing great promise, the next step is to obtain the necessary FDA approvals to begin studying the therapy in humans at OSU Medical Center and other centers around the country.

According to the Centers for Disease Control and Prevention, more than one-third of U.S. adults, or 72 million people, and 16 percent of U.S. children are obese. Since 1980, obesity rates for adults have doubled and rates for children have tripled.

Approximately 24 million U.S. children and adults, nearly eight percent of the population, have diabetes, according to the American Diabetes Association. An estimated 18 million people have been diagnosed with the disease, but nearly six million people are unaware that they have diabetes.

Source: Ohio State University Medical Center

Explore further: Clues to genetics of congenital heart defects emerge from Down syndrome study

add to favorites email to friend print save as pdf

Related Stories

Larger belly in mid-life increases risk of dementia

Mar 25, 2008

People with larger stomachs in their 40s are more likely to have dementia when they reach their 70s, according to a study published in the March 26, 2008, online issue of Neurology, the medical journal of the American Academ ...

Researchers Discover Fat Gene

Jan 20, 2005

UCLA/VA scientists have identified a new gene that controls how the body produces and uses fat. Called lipin, the gene may provide a new target for therapies to control obesity, diabetes and other weight-related disorders. ...

'Skinny gene' does exist, researchers find

Sep 04, 2007

Researchers at UT Southwestern Medical Center have found that a single gene might control whether or not individuals tend to pile on fat, a discovery that may point to new ways to fight obesity and diabetes.

Recommended for you

Right environment could improve stem cell therapies

Oct 23, 2014

Stem cell therapies are being hailed as a potential cure for many major health conditions, but there is much still to learn about the highly complex environments needed to optimise these therapies, according to researchers ...

User comments : 0